Abstract :
Background
Ischemic stroke is a clinical syndrome with rapidly develop loss of brain function
due to disturbance in the blood supply to the brain, due to ischemia (lack of glucose
and oxygen supply) caused by thrombosis or embolism. The role of natural
anticoagulants Protein C, Protein S and Antithrombin III in ischemic stroke is still
not widely known. It is important to look at the levels of Protein C, Protein S and
Antithrombin III before the occurrence of ischemic stroke. The purpose of this
study was to determine differences in levels of protein C, Protein S and
Antithrombin III which were examined on days 1, 3 and 7 in acute ischemic stroke
during treatment.
Method
This study was a longitudinal prospective method carried out in H. Adam Malik
General Hospital Medan, from January to May 2018 in 21 acute ischemic stroke
patients with three times of sampling, namely on day 1, 3 and 7. Examination of
Protein C, Protein S and Antithrombin III uses a Coatron A4 device, Protein C and
Antithrombin III with chromogenic assay principles and Protein S with clotting
assay principles.
Results
21 Patients who participated in the study were 12 men (57.1%), 9 women (42.9%).
The results of Repeated Anova test and Friedman test found no significant
differences on days 1, 3 and 7 for Protein C, Protein S and Antitrombin III.
Correlation test between each Protein C, Protein S and Antithrombin III was
positively and significantly correlated, while the correlation test of Protein C with
Protein S had a no significant positive correlation, Protein C with Antithrombin III
had no significant negative correlation, Protein S with Antithrombin III had no
significant.
Conclusion
Average levels of Protein C, Protein S and Antithrombin III according to statistical
results there is no significant differences on days 1, 3 7. It is recommended that
samples be taken for a longer periode of time.